Multifactorial diseases: principles of diagnosis

Multifactorial diseases are conditions that develop not due to a single mutation, but rather due to the combined effects of numerous genetic variants and environmental factors. This group includes a significant number of the most common human diseases, including arterial hypertension, coronary heart disease, type 2 diabetes, many forms of cancer, arthritis, and some congenital malformations. [1]

The key feature of this group is that the patient typically lacks a single, definitive test that immediately confirms the diagnosis. Current sources indicate that there is no universal test for multifactorial diseases: the diagnosis is based on a combination of complaints, clinical signs, family history, risk factors, laboratory and instrumental data, and genetic information in most cases merely supplements this picture. [2]

That's why diagnosis here is always two-layered. First, the doctor answers the question of whether the patient has the disease itself or its early manifestations. Then, the question of predisposition, that is, the likelihood of developing the disease in the future or the risk of recurrence in the family, is assessed separately. These two tasks are related, but not identical. [3]

The modern approach to such conditions is increasingly shifting from an abstract "genetic nature" to clinically useful risk stratification. This means that physicians must not only provide a diagnosis but also understand who needs earlier testing, who requires more frequent monitoring, and who is indicated for consultation with a medical geneticist. [4]

Therefore, a quality article on this topic must answer not just one, but several questions: what is a multifactorial disease, why is it difficult to diagnose, what role does family history and phenotype play, where does genetic testing fit in, and how can this knowledge be practically applied to common diseases and congenital anomalies. This is the logic behind the subsequent analysis. [5]

Table 1. What is considered a multifactorial disease and what is important for diagnosis

State Group	Examples	What is especially important in diagnostics
Chronic cardiovascular diseases	Arterial hypertension, ischemic heart disease	Blood pressure, lipids, risk factors, family history
Metabolic diseases	Type 2 diabetes, obesity	Body mass index, glucose, glycated hemoglobin, lifestyle
Oncological diseases	Many common forms of cancer	Age, family history, screening, sometimes genetic counseling
Neurological and mental disorders	Some epilepsy, depression, developmental disorders	Detailed phenotype, differential diagnosis, genetics in some cases
Congenital anomalies	Certain congenital heart defects, clefts, neural tube defects	Examination, imaging, family history, recurrence risk assessment

Source: data on common multifactorial diseases and principles of their assessment. [6]

What are multifactorial diseases and why are they difficult to diagnose?

The term "multifactorial disease" implies that the disease arises not from a single causal event, but from the cumulative effect of many influences. These include common genetic variants with minor contributions, familial and population characteristics, diet, body weight, physical activity, smoking, alcohol, infections, age, drug exposure, and other external factors. This structure of causes immediately makes diagnosis more complex than with a classic monogenic disease. [7]

Many of these diseases are characterized by a predisposition that exists long before clinical manifestations, with the disease itself developing gradually. Therefore, the same person may first fall into a high-risk category, then into a subclinical stage, and only later receive a full diagnosis. In practice, this means that diagnosis often begins not with symptoms, but with screening and probability assessment. [8]

The lack of a simple Mendelian pattern of inheritance creates additional complexity. With a monogenic disease, the physician often looks for a clear family pattern of transmission. With multifactorial diseases, this pattern is usually vague: the disease may occur in several relatives, but without a strict pattern of "in every generation" or "only in males." Therefore, the physician must think in probabilities rather than absolute rules. [9]

Another reason for diagnostic difficulties is that the same clinical picture can have different genetic architectures. For example, high blood pressure in one person may be primarily related to age, body weight, and salt sensitivity, while in another it may be a manifestation of a rare secondary condition. Similarly, some patients with a seemingly "common" disease may actually have a rarer monogenic or syndromic form that cannot be missed. This is no longer simply a diagnosis of the disease, but a differential diagnosis of the underlying cause. [10]

This is why modern diagnostics of multifactorial diseases always requires two levels of assessment. The first level answers the question of whether a person has the disease here and now. The second level determines the extent of the genetic predisposition, whether an extended family analysis is needed, whether a "common" disease conceals a hereditary syndrome, and what the risk to relatives is. Without this distinction, diagnostics remain incomplete. [11]

Table 2. Why is it more difficult to diagnose a multifactorial disease?

The reason for the difficulty	What does this mean in practice?
There is no one universal mutation	You can't rely on one confirmatory test
Environmental factors are important	It is necessary to collect lifestyle and associated influences in detail
Probabilistic inheritance	The family picture may be blurred
The disease often develops gradually.	Screening and early detection are especially important
A mixture of the normal and rare forms is possible	Differential diagnostics and sometimes consultation with a geneticist are required.

Source: Current descriptions of multifactorial inheritance and clinical risk assessment. [12]

What does modern diagnostics consist of?

The first stage of diagnosis is a phenotypic assessment, a detailed description of how the disease manifests in a specific patient. This includes the patient's complaints, age of onset, severity, combination of symptoms, examination findings, and the presence of complications. This is especially important for multifactorial diseases, as the phenotype guides further investigation and helps distinguish typical from atypical variants. [13]

The second stage is an analysis of risk factors and the environment. Family medicine and preventive cardiology have long demonstrated that age, excess weight, nutrition, low physical activity, smoking, and alcohol consumption often not only accompany the disease but actually contribute to its development. Therefore, without this information, the diagnostic conclusion will be limited. [14]

The third stage involves standard laboratory and instrumental methods. For arterial hypertension, this includes repeated blood pressure measurements and confirmation outside the clinic. For type 2 diabetes, this includes fasting glucose, glycated hemoglobin, or an oral glucose tolerance test. For colorectal cancer, this includes age- and risk-based screening programs. These examples illustrate the main principle: the diagnosis of a multifactorial disease is confirmed by methods validated specifically for the disease, not simply by a general family history. [15]

The fourth stage is to rule out an alternative or rarer cause. A relatively "common" disease requires a more cautious approach if the onset is too early, the course is too severe, multiple organs are affected, there is a significant familial cluster of cases, or the presentation does not fit the usual clinical scenario. In such cases, the physician should consider a hereditary syndrome, a rare monogenic variant, or a secondary cause of the disease. [16]

The fifth stage is risk stratification and monitoring planning. For multifactorial diseases, diagnosis rarely completes the process. Instead, after diagnosis, it is necessary to determine who needs earlier screening for complications, who requires intensive prevention, who needs evaluation of relatives, and who has grounds for genetic counseling. This is how modern diagnostics differs from simply ascertaining the disease. [17]

Table 3.

Stage	Content
1	Confirmation of clinical phenotype
2	Collection of risk factors and external influences
3	Laboratory and instrumental methods according to the disease profile
4	Exclusion of a rare hereditary or secondary cause
5	Family risk assessment and monitoring plan

Source: summary of modern clinical and genetic approaches to the assessment of complex diseases. [18]

Family history, screening and phenotype: the basis of practical diagnostics

Family history remains one of the most useful tools in diagnosing multifactorial diseases. The US Centers for Disease Control and Prevention explicitly states that family history includes not only shared genes but also shared habits, dietary habits, place of residence, and environmental influences. Therefore, it helps the physician see a more complete picture of risk than an isolated laboratory test. [19]

A thorough family history should include parents, siblings, children, grandparents, aunts, uncles, nephews, and nieces, as well as age at onset, age at death, and cause of death, if known. Particularly important are early onsets of the disease, recurring similar illnesses in several close relatives, and severe forms that appear earlier than usual. These are the kinds of details that can elevate a patient from the usual risk category to the category of increased hereditary risk. [20]

For common chronic diseases, family history often influences not the diagnosis itself, but the age and scope of testing. For example, for those at risk for hypertension, screening is recommended for all adults, but the frequency of monitoring is higher in those over 40 and in those with increased risk. For type 2 diabetes, screening is recommended for adults aged 35-70 who are overweight or obese, and the presence of additional risk factors can help determine the need for earlier testing. [21]

In oncology, the importance of family history is even more pronounced. When a hereditary predisposition to breast and ovarian cancer is suspected, a modern approach suggests first using brief family risk assessment tools. Only if this screening is positive is the patient referred for genetic counseling and, if necessary, testing. This is an important principle: genetic testing is not performed blindly, but after careful selection. [22]

Even with congenital anomalies, family history remains key. For some isolated congenital heart defects, the risk of recurrence in the offspring of the affected parent or family is higher than the population risk and can vary significantly depending on the specific defect. Therefore, if a congenital anomaly is already present, diagnosis for the next pregnancy includes not only ultrasound monitoring but also an individual assessment of familial risk. [23]

Table 4. What is essential to collect in the family history

What needs to be clarified	Why is this important?
What illnesses did close relatives have?	Helps to see family risk concentrations
Age of onset of the disease	Early debut is more alarming in favor of hereditary contribution
Age and cause of death	Allows you to notice underestimated vascular and oncological risks
Identical cases in several relatives	Increases the likelihood of a hereditary predisposition
Ethnic origin and family characteristics	In a number of situations, it influences the choice of tests and risk stratification
The presence of congenital anomalies in children and fetuses	It is necessary for assessing the risk of recurrence and routing the family

Source: Guidelines for family history and risk assessment. [24]

Genetic testing and polygenic risk scores

In modern clinical practice, genetic testing for multifactorial diseases must be understood correctly. It does not replace a diagnosis based on clinical criteria, but rather serves one of three purposes: it helps rule out rarer monogenic forms, clarifies hereditary risk in families with a suspicious history, or potentially complements routine risk assessment for complex polygenic diseases. [25]

Polygenic risk scores are numerical estimates that summarize the contributions of multiple common genetic variants. These scores are being studied particularly actively for cardiovascular disease, breast cancer, type 2 diabetes, and a number of neurological conditions. However, even modern reviews emphasize that their role in routine clinical diagnostics has not yet been fully determined. [26]

One of the main limitations of polygenic risk scores is their variable accuracy across populations. Authors of large reviews and consensus documents point out that the issue of ancestry calibration, the underrepresentation of many populations in the original studies, and the lack of uniform clinical thresholds may limit the transferability of the results to everyday practice. This does not negate the usefulness of the method, but it does require caution. [27]

Therefore, in practice, the following approach is more justified: if the clinical picture and family history point to a possible rare syndrome, a classic clinical examination and targeted genetic counseling take precedence. If, however, the disease is common and without signs of syndromicity, polygenic information is still considered an additional, rather than a decisive, layer of data. In other words, genetics here enhances clinical judgment rather than replaces it. [28]

Another important principle is that any genetic test must be evaluated based on clinical validity and clinical utility. That is, simply identifying variants in the genome is not enough. It's important to understand how the results actually improve diagnosis, prognosis, prevention, or treatment. For common, complex diseases, this remains the primary determinant before the widespread adoption of new tests. [29]

Table 5. The role of genetic methods in multifactorial diseases

Method	What can it give?	Main limitations
Consultation with a medical geneticist	Family risk assessment, selection of testing volume	Requires good phenotyping and family data
Targeted genetic testing	Search for a rare hereditary form or syndrome	It is not necessary for everyone without clinical grounds.
Polygenic risk scores	Additional risk stratification for certain diseases	Not yet standardized for all routine practice
Population-based screening without clinical consideration	Can identify risk groups	Risk of overestimation of benefits and misinterpretation
A test without proven clinical utility	Gives a risk figure	May not change tactics and be misleading

Source: Current documents on the implementation of genetic tests and polygenic risk scores. [30]

Practical diagnostic scenarios for common multifactorial diseases

Arterial hypertension is a good example of how a multifactorial disease is diagnosed in reality. Screening is recommended for all adults 18 years and older, but a single in-office measurement is not enough to make a diagnosis. Current recommendations call for confirming persistently elevated blood pressure with measurements outside the clinic, preferably through ambulatory monitoring or home monitoring. This is the classic model: first identify, then confirm, and then assess risk factors and complications. [31]

Type 2 diabetes is diagnosed differently, but the logic is similar. Asymptomatic adults aged 35-70 who are overweight or obese are recommended to undergo screening. This is done using fasting glucose, glycated hemoglobin, or an oral glucose tolerance test. While the disease itself is multifactorial, the diagnosis is confirmed not by genes, but by validated biochemical criteria. [32]

Colorectal cancer also clearly demonstrates the difference between general and increased risk. Most people need screening starting at age 45, but earlier screening and a different frequency are required for inflammatory bowel disease, a family history of colorectal cancer or polyps, and hereditary syndromes such as familial adenomatous polyposis and Lynch syndrome. Here, family history influences not the actual occurrence of the disease, but rather the diagnostic and preventative measures. [33]

In the area of breast and ovarian cancer, a stepwise approach is particularly important. Women with a personal or family history of these tumors, or with a certain ancestry, are recommended to undergo a brief family risk assessment. If a positive result is found, a consultation with a genetic specialist is necessary, and only then, if warranted, testing is performed. This approach protects against both missed and unwarranted tests. [34]

For congenital malformations, the diagnostic approach is even more complex. A child's existing defect requires a precise description of the defect, a search for syndromic features, an analysis of the family history, and an assessment of the risk of recurrence. For congenital heart defects, the familial risk of recurrence is usually higher than the population risk and depends on the specific defect. Therefore, in such families, diagnosis is never limited to the statement "it was a coincidence." A specific risk assessment for future pregnancies is needed. [35]

When to refer to a medical geneticist and how to assess the risk to the family

Not every patient with a multifactorial disease requires a medical geneticist. However, a referral is warranted if the disease has an unusually early onset, is severe, is associated with congenital anomalies, is present in several close relatives, or appears atypical for a typical multifactorial disorder. In these cases, the goal is not only to confirm the diagnosis but also to rule out a hereditary syndrome or a rarer genetic cause. [36]

When assessing familial risk for multifactorial diseases, empirical, i.e., observational, recurrence estimates are often used. This is important because classical Mendelian proportions cannot be simply used for complex diseases. Reviews on genetic counseling emphasize that empirical risks remain the most accessible tool for assessing recurrence for many complex conditions. [37]

The general rule for multifactorial inheritance is that the risk is higher in first-degree relatives and decreases with increasing genetic distance. Furthermore, it usually increases with a more severe phenotype, early onset, and the presence of multiple affected relatives. These patterns do not provide an exact figure for all diseases at once, but they help the physician understand when a family situation falls outside the population risk range. [38]

Consultation is especially important in families with a previously born child with a congenital anomaly. Three tasks must be addressed here: more accurately classifying the defect itself, determining whether it is part of a syndrome, and assessing the risk of recurrence in future pregnancies. For example, with isolated congenital heart defects, the risk of recurrence is higher than background risk, but its magnitude depends on the specific defect and family structure. Therefore, generalized answers without a specific diagnosis are harmful. [39]

Ultimately, a medical geneticist is needed not for the consultation itself, but for decision-making. After such an assessment, the family can gain a more accurate understanding of the prognosis, the timing and extent of prenatal care, the need to screen relatives, and the real benefits of genetic testing. This is especially valuable for multifactorial diseases, because not only biology but also effective risk communication is crucial. [40]

Table 6. When a consultation with a medical geneticist is especially warranted

Situation	Why is a consultation necessary?
Early and unusually severe onset of the disease	A rare hereditary form must be ruled out.
Several identical cases in close relatives	The likelihood of a significant hereditary contribution increases
Congenital anomaly in a child	An assessment of the risk of recurrence and syndromicity is required.
A combination of several organs or systems	A hereditary syndrome is possible
Positive family risk factor for cancer	The issue of counseling and testing needs to be resolved.
An unclear clinical case after a standard examination	Genetic assessment may change the diagnostic route

Source: Current guidelines for family risk assessment and genetic counseling. [41]

Conclusion

Diagnosis of multifactorial diseases is not a search for a single "disease gene," but rather a consistent clinical approach that considers probability, phenotype, family history, environmental factors, and confirmatory tests specific to the disease profile. Therefore, there is no universal laboratory test for this group of diseases. [42]

The mainstay of modern practice is a properly collected family history, disease-specific diagnostic criteria, and reasonable risk stratification. For arterial hypertension, type 2 diabetes, colorectal cancer, familial-associated cancers, and congenital anomalies, this has long been formalized into specific screening pathways. [43]

Genetic methods and polygenic risk scores will play an increasingly important role, but their place today must be assessed soberly. They are useful as a complement to clinical examination, not as a replacement. The safest and most modern approach is to first accurately describe the disease and family situation, and then decide whether and to what extent genetic testing is needed. [44]

FAQ

What is a multifactorial disease?

It is a disease that develops due to a combination of multiple genetic and environmental factors, rather than a single mutation. Such conditions include a significant number of common chronic diseases and some congenital anomalies. [45]

Is there one test for all multifactorial diseases?

No. Current clinical and genetic evidence suggests that there is no universal test for all multifactorial diseases. Diagnosis depends on the specific disease and is confirmed by specialized clinical, laboratory, and instrumental methods. [46]

Why is family history so important?

Because it reflects not only shared genes but also shared habits, diet, environment, and age of disease onset in relatives. This information helps understand the risk, determine the scope of testing, and determine when to begin screening. [47]

When do you need a medical geneticist?

Consultation is especially important in cases of early onset, severe or atypical course, recurrent cases in close relatives, congenital anomalies, combined lesions of several systems, and positive family risk factors in oncology. [48]

Can a diagnosis be made with just a genetic test?

For most multifactorial diseases, no. Genetic data usually serve as an adjunct to the clinical picture and help refine risk, rather than replacing standard diagnostic criteria. [49]

What are polygenic risk scores?

These are calculated indicators that summarize the contribution of many common genetic variants to predisposition to a complex disease. They are promising, but have not yet become a universal standard for routine diagnostics for all conditions. [50]

How is the risk of disease recurrence assessed in a family?

For many complex conditions, empirical estimates based on observational data rather than simple Mendelian proportions are used. Risk is typically higher in first-degree relatives, with multiple affected relatives, and with a more severe phenotype. [51]

How does the diagnosis of multifactorial disease differ in adults and children?

In adults, the emphasis is more often on screening, risk factors, and confirmation of diagnosis with standard tests. In children and with congenital anomalies, phenotyping, the search for syndromic features, family history, and assessment of the risk of recurrence in future pregnancies are of greater importance. [52]